Aveanna Healthcare (AVAH) holders sell 16.8M shares in offering
Rhea-AI Filing Summary
Aveanna Healthcare Holdings, Inc. (AVAH) reported that entities associated with reporting person Robert M. Williams, Jr., a ten percent owner, executed a series of indirect sales of 16,750,002 shares of common stock at $11.50 per share on August 20–21, 2026. According to the footnotes, J.H. Whitney VII, L.P., PSA Healthcare Investment Holding LLC, JHW Iliad Holdings, LLC, JHW Iliad Holdings II, LLC and PSA Iliad Holdings LLC sold these shares in an underwritten secondary offering, including sales pursuant to an option to purchase additional shares. Williams is described as associated with the managing or controlling entities of these stockholder entities and disclaims beneficial ownership of the securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 16,750,002 shares
Net Sell
7 txns
Insider
WILLIAMS ROBERT M JR
Role
10% Owner
Sold
16,750,002 shs ($192.63M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.01 par value F10, F1 | 2,250,000 | $11.50 | $25.88M |
| Sale | Common Stock, $0.01 par value F5, F1 | 10,112,125 | $11.50 | $116.29M |
| Sale | Common Stock, $0.01 par value F6, F1 | 957,918 | $11.50 | $11.02M |
| Sale | Common Stock, $0.01 par value F7, F2 | 1,813,795 | $11.50 | $20.86M |
| Sale | Common Stock, $0.01 par value F8, F1 | 1,426,034 | $11.50 | $16.40M |
| Sale | Common Stock, $0.01 par value F9, F2, F3 | 190,130 | $11.50 | $2.19M |
| holding | Common Stock, $0.01 par value F4 | -- | -- | -- |
Holdings After Transaction:
Common Stock, $0.01 par value — 0 shares (Indirect, By J.H. Whitney VII, L.P.);
Common Stock, $0.01 par value — 0 shares (Indirect, By JHW Iliad Holdings, LLC);
Common Stock, $0.01 par value — 0 shares (Indirect, By PSA Iliad Holdings LLC);
Common Stock, $0.01 par value — 0 shares (Indirect, By JHW Iliad Holdings II, LLC);
Common Stock, $0.01 par value — 12,315,892 shares (Indirect, By PSA Healthcare Investment Holding LLC);
Common Stock, $0.01 par value — 0 shares (Direct)
Footnotes (10)
- F1. J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F2. Project Iliad Managing Member, LLC ("Project Iliad") is the managing member of JHW Iliad Holdings LLC ("JHW Iliad"). As a result, Project Iliad may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad. Project Iliad disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F3. J.H. Whitney Capital Partners, LLC ("Capital Partners") is the sole member of J.H. Whitney VII Management Co., LLC ("Management Co. VII"), which is the managing member of JHW Iliad Holdings II LLC ("JHW Iliad II," and, collectively with PSA Healthcare, JHW Iliad, and PSA Iliad Holdings, the "Stockholder Entities"). As a result, each of Capital Partners and Management Co. VII may be deemed to share voting and dispositive power with respect to the Shares held by JHW Iliad II. Each of Capital Partners and Management Co. VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
- F4. Robert M. Williams, Jr is a Managing Member of Equity Partners VII, a Member of Project Iliad and a Senior Managing Director of Capital Partners. As a result, the undersigned may be deemed to share voting and dispositive power with respect to the Shares held by the Stockholder Entities. The undersigned disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F5. On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
- F6. On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
- F7. On August 20, 2026, JHW Iliad Holdings, LLC sold 1,813,795 Shares pursuant to an underwritten secondary offering.
- F8. On August 20, 2026, JHW Iliad Holdings II, LLC sold 190,130 Shares pursuant to an underwritten secondary offering.
- F9. On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
- F10. On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.
Key Figures
Total shares sold: 16,750,002 shares
Sale price per share: $11.50 per share
Shares sold by J.H. Whitney VII, L.P.: 10,112,125 shares
+4 more
7 metrics
Total shares sold
16,750,002 shares
Aggregate non-derivative sales on August 20–21, 2026
Sale price per share
$11.50 per share
Price for each reported sale transaction
Shares sold by J.H. Whitney VII, L.P.
10,112,125 shares
Underwritten secondary offering on August 20, 2026
Shares sold by PSA Healthcare Investment Holding LLC (Aug 20)
957,918 shares
Underwritten secondary offering on August 20, 2026
Shares sold by PSA Healthcare Investment Holding LLC (Aug 21)
2,250,000 shares
Pursuant to option to purchase additional shares
Shares sold by JHW Iliad Holdings, LLC
1,813,795 shares
Underwritten secondary offering on August 20, 2026
Shares sold by PSA Iliad Holdings LLC
1,426,034 shares
Underwritten secondary offering on August 20, 2026
Key Terms
underwritten secondary offering, disclaims beneficial ownership, voting and dispositive power, pecuniary interest, +1 more
5 terms
underwritten secondary offering financial
"sold 10,112,125 Shares pursuant to an underwritten secondary offering"
An underwritten secondary offering is when existing shareholders sell a block of already-issued shares and an investment bank agrees to buy and resell them to the public, guaranteeing the sale will go through. Think of it as a store owner pre-selling a large shipment to a wholesaler who then sells it to customers; for investors, it can increase the number of shares available, affect short-term price pressure, and signal that insiders are taking profits or diversifying holdings.
disclaims beneficial ownership financial
"disclaims beneficial ownership of such securities except to the extent"
voting and dispositive power financial
"may be deemed to share voting and dispositive power with respect"
pecuniary interest financial
"except to the extent of its pecuniary interest therein"
indirect ownership financial
"ownership_type": "indirect""
FAQ
What insider activity did AVAH disclose for Robert M. Williams, Jr. on this Form 4?
The filing reports indirect sales of 16,750,002 shares of Aveanna common stock on August 20–21, 2026 at $11.50 per share, executed by several affiliated entities in an underwritten secondary offering.
Were the Aveanna (AVAH) insider sales made under a Rule 10b5-1 trading plan?
The document-level Rule 10b5-1 checkbox is false, indicating the reported transactions were not affirmed as being made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
